What is ECRI?
ECRI operates as a globally recognized and trusted entity by healthcare leaders and government agencies. For over five decades, it has maintained its independence through strict conflict-of-interest policies, solidifying its reputation for integrity and rigorous research. ECRI is unique in its global capacity to perform independent evaluations of medical devices, with testing laboratories strategically located in North America and the Asia Pacific region. Its designation as an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality and its certification as a Patient Safety Organization by the U.S. Department of Health and Human Services further attest to its authoritative stance in the healthcare sector. The integration of the Institute for Safe Medication Practices (ISMP) in 2020 further broadens its impact on patient safety.
How much funding has ECRI raised?
ECRI has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in ECRI
PPP
Public-Private Partnership
What's next for ECRI?
The recent major strategic investment in ECRI signals a strong endorsement of its foundational work in healthcare improvement and patient safety. This capital infusion is expected to bolster ECRI's capacity for independent research, technology assessment, and the dissemination of evidence-based practices. As ECRI continues to navigate the complexities of modern healthcare, this funding will likely support the expansion of its evaluation services, enhance its technology infrastructure, and potentially broaden its reach to new markets or healthcare settings. The company's focus on patient safety and cost-effectiveness positions it to address emerging challenges and opportunities within the global healthcare landscape.
See full ECRI company page
